Chronic Myeloid Leukemia Therapy: Focus on Second-Generation Tyrosine Kinase Inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Chronic Myeloid Leukemia Therapy: Focus on Second-Generation Tyrosine Kinase Inhibitors

Published:2009-04 Issue:2 Volume:16 Page:132-140
ISSN:1073-2748
Container-title:Cancer Control
language:en
Short-container-title:Cancer Control

Author:

McFarland K. Leigh¹²³,Wetzstein Gene A.¹

Affiliation:

1. Malignant Hematology Program, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida.

2. Department of Pharmacy at the H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida.

3. Department of Pharmacy at the University of Kansas Hospital, Kansas City, Kansas.

Publisher

SAGE Publications

Subject

Oncology,Hematology,General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/107327480901600205

Reference55 articles.

1. The Bcr-Abl tyrosine kinase inhibitor imatinib and promising new agents against Philadelphia chromosome-positive leukemias

2. Current and emerging treatment options in chronic myeloid leukemia

3. The Biology of Chronic Myeloid Leukemia

4. The molecular biology of chronic myeloid leukemia

5. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Loss of PRMT7 reprograms glycine metabolism to selectively eradicate leukemia stem cells in CML;Cell Metabolism;2022-06

2. Developing role of B cells in the pathogenesis and treatment of chronic GVHD;British Journal of Haematology;2018-12-26

3. Dasatinib for the treatment of chronic myeloid leukemia: patient selection and special considerations;Drug Design, Development and Therapy;2016-10

4. Imatinib and dasatinib as salvage therapy for sclerotic chronic graft-vs-host disease;Croatian Medical Journal;2016-06

5. Imatinib for treating patients with chronic myelogeneous leukemia;Cochrane Database of Systematic Reviews;2015-10-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3